Entries by Steve

TARGET PharmaSolutions® Launches TARGET-DERM Real-World Observational Study to Advance the Understan

DURHAM, N.C., Feb. 13, 2019 /PRNewswire/ — TARGET PharmaSolutions, Inc., a company focused on real-world evidence, announced today that it launched its latest large-scale observational study, TARGET-DERM (NCT03661866).  The study will deliver real-world evidence for several immune-mediated inflammatory skin conditions (IMISCs), initially focusing on patients with atopic dermatitis (AD/eczema).  TARGET-DERM’s first participant enrolled on January 25, […]

Global Analysis on Humira Industry Market Research Report 2019-2024| Market Status and Future Forecast Overview by Leading Manufacturers- AbbVie, Eisai, Cadila Healthcare, Torrent Pharmaceuticals and More Announced at MarketResearchNest.com

Humira Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024-adds by MarketResearchNest Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, […]

Carmignac Gestion Holds Stake in Chemocentryx (CCXI); International Flavors & Fragra (IFF) Market Value Rose While Btim Lifted by $1.09 Million Its Stake

Carmignac Gestion increased its stake in Chemocentryx Inc (CCXI) by 26.83% based on its latest 2018Q3 regulatory filing with the SEC. Carmignac Gestion bought 275,273 shares as the company’s stock declined 9.75% with the market. The institutional investor held 1.30 million shares of the health care company at the end of 2018Q3, valued at $16.45 […]

Analysts See $-0.28 EPS for ChemoCentryx, Inc. (CCXI); Nutrisystem (NTRI) Sellers Decreased By 11.77% Their Shorts

Nutrisystem Inc (NASDAQ:NTRI) had a decrease of 11.77% in short interest. NTRI’s SI was 6.02 million shares in February as released by FINRA. Its down 11.77% from 6.82 million shares previously. With 613,200 avg volume, 10 days are for Nutrisystem Inc (NASDAQ:NTRI)’s short sellers to cover NTRI’s short positions. The SI to Nutrisystem Inc’s float […]

Jpmorgan Chase & Company Has Trimmed Chemocentryx (CCXI) Stake; Profile of 2 Analysts Covering Columbia Banking System, Inc. (COLB)

Jpmorgan Chase & Company decreased Chemocentryx Inc (CCXI) stake by 97.36% reported in 2018Q3 SEC filing. Jpmorgan Chase & Company sold 192,027 shares as Chemocentryx Inc (CCXI)’s stock declined 9.75%. The Jpmorgan Chase & Company holds 5,203 shares with $66,000 value, down from 197,230 last quarter. Chemocentryx Inc now has $545.17M valuation. The stock decreased […]

ChemoCentryx, Inc. (CCXI) Reaches $10.97 After 8.00% Down Move; Credit Suisse Ag Lowered Its Spartannash Co (SPTN) Holding

Credit Suisse Ag decreased Spartannash Co (SPTN) stake by 26.97% reported in 2018Q3 SEC filing. Credit Suisse Ag sold 36,391 shares as Spartannash Co (SPTN)’s stock declined 16.96%. The Credit Suisse Ag holds 98,526 shares with $1.98 million value, down from 134,917 last quarter. Spartannash Co now has $763.00 million valuation. It closed at $21.23 […]

Artisan Partners Asset Management (APAM) to pay $0.56 on Feb 28, 2019; Inflarx N.V. (IFRX) Shorts Lowered By 1.57%

Artisan Partners Asset Management Inc (NYSE:APAM) is expected to pay $0.56 on Feb 28, 2019. (NYSE:APAM) shareholders before Feb 13, 2019 will receive the $0.56 dividend. Artisan Partners Asset Management Inc’s current price of $25.28 translates into 2.22% yield. Artisan Partners Asset Management Inc’s dividend has Feb 14, 2019 as record date. Feb 5, 2019 […]